The Infection Control Today® COVID-19 page brings readers the latest information and clinical updates on the coronavirus disease 2019 pandemic, from case counts and hospitalization rates to data on effective treatments for severe disease and the circulating viral variants.
June 11th 2025
As federal cuts reshape public health, students nationwide are reacting with fear, frustration, and renewed resolve as they face an uncertain future in the field.
Pooled Saliva Testing for Newborns Enhances Early Detection of Congenital Cytomegalovirus
May 23rd 2024Hadassah Medical Organization's pooled saliva testing for newborns effectively screens for congenital cytomegalovirus, identifying asymptomatic cases and potentially reducing severe cognitive and auditory problems globally.
Advancing Viral Disease Treatment of Recurrent Genital Herpes, Hepatitis B and D Viruses
May 2nd 2024Health care has an unmet need for the treatment of herpesviruses, hepatitis B, and hepatitis D, which would enhance patient outcomes. What should be done, and what challenges do companies that are trying to develop treatments face?
Healing With Algorithms: AI's Impact on Epidemiology and Infection Control
April 2nd 2024Media in the US presents AI as both beneficial and risky. Positive coverage shows AI's potential through virtual assistants like Siri, while cautionary tales warn of misuse like misinformation and deepfakes. How does all this work in health care?
Four Years After COVID-19: What Has the Infection Prevention Community Learned?
March 15th 2024Four years ago today, March 15, 2020, the COVID-19 lockdown began, and since then, the world has undergone significant changes. It has been a terrifying experience for everyone, especially for the infection prevention community, both within and outside of the health care sector. However, a crucial question remains unanswered: What has the infection prevention community learned from this pandemic, and where does it go from here?
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Meet Infection Control Today's Editorial Board Member: Tabrikah Mohammed, MSc, BSN, CIC, CPHQ, FAPIC
Published: March 5th 2024 | Updated: August 6th 2024Meet the experts shaping infection prevention: Infection Control Today's Editorial Board members share insights, experiences, and cutting-edge strategies to enhance health care safety and quality. Meet Tabrikah Mohammed, MSc, BSN, CIC, CPHQ, FAPIC.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.
CSL's ARCT-154: The World’s First Self-Amplifying mRNA Vaccine Approved for COVID-19 in Adults
February 1st 2024CSL achieves a global milestone as Japan approves ARCT-154, the first sa-mRNA COVID-19 vaccine, showcasing CSL's commitment to innovation, efficacy, and prolonged protection against variants. Jonathan Edelman, MD, senior VP of CSL Vaccine’s Innovation Unit, speaks with ICT.
Infection Control Today's Round Table Focuses on Burnout: Recognition, Stigma, and Prevention
January 30th 2024Frontline infection preventionists (IPs) face burnout due to challenges in public health. This Round Table on IP Burnout discusses strategies to prevent and address this critical issue. The IPs emphasize the importance of understanding burnout, recognizing signs, addressing stigma, and implementing multilayered prevention strategies for both individuals and organizations.
Balancing Act: Insights From an Infection Preventionist, Mother, and Volunteer
January 30th 2024Jill E. Holdsworth, MS, CIC, FAPIC, NREMT, CRCST, prevention manager, discusses the challenges of balancing work, family, and volunteering, emphasizing the importance of prioritizing self-care and personal interests.